Us Bancorp \De\ Ascendis Pharma A/S Transaction History

Us Bancorp \De\

$77.3 Billion
Q3 2024

A detailed history of Us Bancorp \De\ transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Us Bancorp \De\ holds 288 shares of ASND stock, worth $40,435. This represents 0.0% of its overall portfolio holdings.

Number of Shares

288

Previous 310 7.1%

Holding current value

$40,435

Previous $42,000 2.38%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$113.0 - $153.43 $2,486 - $3,375	-22 Reduced 7.1%	288 $43,000
Q2 2024 Aug 06, 2024	SELL	$121.07 - $153.67 $726 - $922	-6 Reduced 1.9%	310 $42,000
Q1 2024 May 07, 2024	BUY	$123.45 - $159.4 $3,950 - $5,100	32 Added 11.27%	316 $47,000
Q4 2023 Feb 09, 2024	BUY	$86.1 - $127.36 $6,371 - $9,424	74 Added 35.24%	284 $35,000
Q3 2023 Nov 03, 2023	BUY	$86.5 - $103.97 $4,152 - $4,990	48 Added 29.63%	210 $19,000
Q2 2023 Aug 09, 2023	SELL	$69.96 - $97.84 $63,033 - $88,153	-901 Reduced 84.76%	162 $14,000
Q1 2023 May 09, 2023	SELL	$104.9 - $126.78 $15,210 - $18,383	-145 Reduced 12.0%	1,063 $113,000
Q4 2022 Feb 13, 2023	SELL	$99.42 - $131.97 $4,473 - $5,938	-45 Reduced 3.59%	1,208 $147,000
Q3 2022 Oct 27, 2022	BUY	$84.03 - $110.23 $23,780 - $31,195	283 Added 29.18%	1,253 $130,000
Q2 2022 Aug 01, 2022	BUY	$78.08 - $117.61 $27,874 - $41,986	357 Added 58.24%	970 $90,000
Q1 2022 May 11, 2022	SELL	$102.18 - $135.75 $14,509 - $19,276	-142 Reduced 18.81%	613 $72,000
Q4 2021 Feb 11, 2022	SELL	$127.1 - $169.66 $20,844 - $27,824	-164 Reduced 17.85%	755 $101,000
Q3 2021 Nov 10, 2021	BUY	$112.67 - $176.92 $18,703 - $29,368	166 Added 22.05%	919 $146,000
Q2 2021 Aug 05, 2021	SELL	$121.62 - $145.29 $7,662 - $9,153	-63 Reduced 7.72%	753 $99,000
Q1 2021 Apr 28, 2021	BUY	$124.92 - $173.33 $19,112 - $26,519	153 Added 23.08%	816 $106,000
Q4 2020 Feb 04, 2021	BUY	$151.2 - $182.76 $1,663 - $2,010	11 Added 1.69%	663 $111,000
Q3 2020 Nov 10, 2020	SELL	$134.29 - $154.32 $47,135 - $54,166	-351 Reduced 35.0%	652 $101,000
Q2 2020 Aug 07, 2020	BUY	$110.87 - $156.01 $44,458 - $62,560	401 Added 66.61%	1,003 $148,000
Q1 2020 May 13, 2020	BUY	$97.01 - $145.11 $21,051 - $31,488	217 Added 56.36%	602 $68,000
Q4 2019 Feb 04, 2020	BUY	$91.45 - $139.12 $19,844 - $30,189	217 Added 129.17%	385 $53,000
Q3 2019 Nov 08, 2019	BUY	$95.8 - $118.9 $2,011 - $2,496	21 Added 14.29%	168 $16,000
Q2 2019 Aug 13, 2019	BUY	$107.11 - $132.09 $1,713 - $2,113	16 Added 12.21%	147 $17,000
Q1 2019 May 08, 2019	BUY	$62.15 - $129.99 $3,418 - $7,149	55 Added 72.37%	131 $15,000
Q3 2017 Nov 13, 2017	BUY	$26.89 - $37.1 $2,043 - $2,819	76	76 $3,000

Others Institutions Holding ASND

# of Institutions

244

Shares Held

58.8M

Call Options Held

250K

Put Options Held

377K

View Full List

About Ascendis Pharma A/S

Ticker ASND
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,810,200
Market Cap $7.84B
Description
Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...

More about ASND

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account